Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Chronic myeloid leukemia in Asia.
Int J Hematol. 2009 Jan;89(1):14-23. doi: 10.1007/s12185-008-0230-0. Epub 2008 Dec 20.
Int J Hematol. 2009.
PMID: 19101781
Review.
Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent.
Kim SH, Kim D, Kim DW, Goh HG, Jang SE, Lee J, Kim WS, Kweon IY, Park SH.
Kim SH, et al. Among authors: kweon iy.
Hematol Oncol. 2009 Dec;27(4):190-7. doi: 10.1002/hon.894.
Hematol Oncol. 2009.
PMID: 19274615
Item in Clipboard
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy.
Goh HG, Kim YJ, Kim DW, Kim HJ, Kim SH, Jang SE, Lee J, Kim D, Kim WS, Park SH, Kweon IY.
Goh HG, et al. Among authors: kweon iy.
Leuk Lymphoma. 2009 Jun;50(6):944-51. doi: 10.1080/10428190902926973.
Leuk Lymphoma. 2009.
PMID: 19479613
Item in Clipboard
Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors.
Kim WS, Kim D, Kim DW, Kweon IY, Kim SH, Goh HG, Park SH, Lee J.
Kim WS, et al. Among authors: kweon iy.
Hematol Oncol. 2010 Jun;28(2):82-8. doi: 10.1002/hon.918.
Hematol Oncol. 2010.
PMID: 19768693
Item in Clipboard
Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations.
Kim D, Kim DW, Cho BS, Goh HG, Kim SH, Kim WS, Lee J, Kweon IY, Park SH, Yoon JH, Kim ND, Chun H.
Kim D, et al. Among authors: kweon iy.
Leuk Res. 2009 Sep;33(9):1260-5. doi: 10.1016/j.leukres.2008.12.017. Epub 2009 Feb 6.
Leuk Res. 2009.
PMID: 19201023
Item in Clipboard
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
Chae YK, Kang SK, Kim MS, Woo J, Lee J, Chang S, Kim DW, Kim M, Park S, Kim I, Keam B, Rhee J, Koo NH, Park G, Kim SH, Jang SE, Kweon IY, Sidransky D, Moon C.
Chae YK, et al. Among authors: kweon iy.
PLoS One. 2008 Jul 9;3(7):e2594. doi: 10.1371/journal.pone.0002594.
PLoS One. 2008.
PMID: 18612408
Free PMC article.
Item in Clipboard
Cite
Cite